Conference Details

Conference Chairs

Prof . Mohammed Taha Al-Hariri

Conference chair

Department of physiology, College of Medicine, Imam Abdulrahman Bin Faisal University
Kingdom of Saudi Arabia

Prof . Dr. Vitalina Babenko

Conference co-chair

Kharkiv National University, Ukraine

Technical Program Committee

Dr. Alireza Heidari
(Chair of Technical Program Committee)
American International Standards Institute (AISI)
New York
Dr. Latifa AgamalievaHead of Science Department
Azerbaijan University, Baku, Azerbaijan
Prof. Tayeb HAMAIZIAProfessor, Larbi Ben M'hidi university
Prof. Dr. Alireza HeidariFull Distinguished Professor and Academic Tenure of Chemistry &
Enrico Fermi Distinguished Chair in Molecular Spectroscopy &
Head of Cancer Research Institute (CRI) &
Director of the BioSpectroscopy Core Research Laboratory (BCRL) at
Faculty of Chemistry, California South University (CSU), Irvine, California, USA
Prof. Youcef SMARA
Professeur et Directeur de recherche
Université des Sciences et de la Technologie "Houari Boumediene"
Faculté de Génie Electrique
Laboratoire de Traitement d'Images et Rayonnement (LTIR)
BP n°32, El-Alia, 16111, Bab-Ezzouar, Alger, Algerie.
Prof. Volodymyr RomanovHead of Data Acquisition Systems Department Glushkov Institute of Cybernetics of Ukrainian National Academy of Sciences B12
Prof. Dr. F. Smarandache, University of New Mexico, USA
Prof. Dr. B. PapadopoulosDemocritus University of Thrace, Greece
Prof. Dr. A.-B. M. SalemAin Shams University, Cairo, Egypt
Prof. Dr. M. PalVidyasagar University, West Bengal, India
Dr. S. BroumiHassan II University, Casablanca, Morocco
Dr. A. PalNational Institute of Technology, Durgapur, West Bengal, India
Prof. Dr. Magda M. Aly King Abdulaziz University, Saudi Arabia
Prof. Dr. Mayson Alkhatib University of Nizwa , Oman
Prof. Dr. Fardos Bokhari King Abdulaziz University, Saudi Arabia
Prof. Dr. Hanan H OmarTanta University, Tanta, Egypt
Prof. Dr. Nadia O noor King Abdulaziz University, Saudi Arabia
Prof. Dr. Salah Abo AbaKing Abdulaziz University, Saudi Arabia
Prof. Dr. Sanaa E. TorkNational Research Center, Egypt
Dr. Samyah JastanyahKing Abdulaziz University, Saudi Arabia
Dr.Rawan AboashiKing Fiscal hospital
Prof. Salha AlagiliFaculty of Science , Kau, SA
Prof. Sahar HadadeFaculty of Science , Kau, SA
Prof. Rahma AlshamaraniFaculty of Science , Kau, SA
Prof. Buthina AlaidarrosFaculty of Science , Kau, SA
Prof. Haeazin KhalafFaculty of Science , Kau, SA
Prof. Taghreed JamalFaculty of Science , Kau, SA
Prof. Kholode AlzahraniFaculty of Science , Tabok University, SA
Prof. Maha RashedFaculty of Science , Jeddah University, SA
Prof. Lina bahamdanFaculty of Science , Kau, SA

Key Note Speakers

Prof . Mohammed Taha Al-Hariri

Imam Abdulrahman Bin Faisal University
Kingdom of Saudi Arabia

Juan E. Trinidad Segovia

Full professor of finance,
Catedrático de Universidad,
Universidad de Almería, Spain

PhotoNameSpecial Session Name and Topics
Prof. Mohammed Taha Al-Hariri

Department of physiology, College of Medicine, Imam Abdulrahman Bin Faisal University

Kingdom of Saudi Arabia

ICMH24-SSN-1: Physiological and Therapeutic properties of Natural Products on:
Diabetes mellitus, malignancy, and Ageing

Please select this track name when you submit your paper in EasyChair

Session information
Nowadays, scientists highlight the importance of natural compounds in managing type 2 diabetes mellitus (T2DM) and its related complications, including microvascular, macrovascular, and neuropathic complications. The researchers emphasize the importance of discovering biologically active lead compounds or new therapeutic agents from natural sources to address the challenges faced by current antidiabetic drugs. Natural compounds have shown promising effects in improving insulin resistance, reducing inflammation, and managing oxidative stress in diabetes, suggesting that more research is needed to fully understand and harness the benefits of these compounds in diabetes management.
Several reports discuss the recent advances in the effects of natural compounds on malignancy. Natural compounds have shown significant antitumor effects on cancer, which have shown possible benefits in treating cancer patients through various mechanisms. The articles highlight the potential of natural products in treating drug-resistant cancer, which is a significant challenge in cancer treatment as well as the molecular mechanisms of drug resistance in cancer, including drug accumulation and absorption reduction, inactivation of drug or alteration of drug target, inhibition of apoptosis-related gene expression.
The effect of natural compounds on ageing is well reported, it is including the discovery of bioactive compounds and their derivatives that can delay ageing and improve ageing-associated diseases, thereby prolonging the lifespan.
Although many natural compounds that could be useful in these conditions have already been characterized, further investigations and validations are still needed, and the drive remains to identify novel natural molecules with higher clinical safety and efficacy profiles for the lifelong treatment of a large part of the global population. Thus, this session welcomes original research papers and literature reviews concerning this important topic.
Scope and Interests (not limited to)
• Natural compounds
• Chronic diseases
• Ageing
• Age-related diseases
• Endothelial dysfunction
• Inflammation
• Diabetes mellitus
• Antioxidant
• Cytokines
• Phytochemicals
• Malignancy

2023 International Conference on Innovation of Communication and Information Technology (ICIEICT 2023).